Taking codeine and Mounjaro together: the key questions answered

Why gut-motility matters when codeine and Mounjaro share the picture

Codeine is an opioid analgesic. One of its well-known effects is slowing the movement of the bowel, it reduces gut motility, which is why constipation is so common when people take it regularly. Mounjaro works partly through a different route: as a dual GIP and GLP-1 receptor agonist, it slows gastric emptying as part of how it reduces appetite and lowers post-meal blood sugar. Both agents, then, are nudging the gut in the same direction. For most people this will not cause a serious problem, but it does mean constipation risk is additive, and any existing gut discomfort may be amplified during the dose-adjustment phase of tirzepatide. If you want to read more about how the medicine itself works, the tirzepatide overview on our site covers the mechanism in plain terms.

The NHS patient information for tirzepatide notes that nausea, constipation, vomiting and diarrhoea are the most commonly reported side effects, particularly in the weeks after starting or increasing a dose. Layering a constipating opioid on top of that picture is something a prescriber will want to weigh carefully against your reasons for taking codeine and how regularly you use it.

The absorption question: does Mounjaro change how codeine works in your body?

Because Mounjaro slows the rate at which the stomach empties, it can theoretically affect how quickly oral medicines reach the small intestine and are absorbed. This is a recognised class effect for GLP-1 and dual-agonist medicines. For most drugs with wide therapeutic windows the practical impact is small. Codeine sits in a more nuanced position: it is itself a prodrug, converted in the liver to morphine by the CYP2D6 enzyme, and absorption timing could in principle affect the onset and shape of its analgesic effect, even if the total amount absorbed stays similar. The Mounjaro SmPC, available to read on the electronic Medicines Compendium, advises prescribers to be alert to this class effect for any co-administered oral medicine that is time-sensitive. Codeine used occasionally for mild pain is a different clinical picture from regular high-dose use, and that distinction matters when your prescriber is making a decision.

Worth noting: the combination is not listed as contraindicated. What it is, is a conversation your prescriber should lead. If you are a transfer patient or have an existing prescription, our team reviews your full medicines list as part of the Mounjaro assessment process.

Practical steps before you start Mounjaro if you use codeine

The decision framework here is straightforward. First, list every medicine you take, including any codeine-containing products bought over the counter. Second, tell your prescriber how often you take codeine: a single tablet after a dental procedure is very different from daily use for chronic pain. Third, consider whether the reason you take codeine is itself weight-related, conditions like osteoarthritis are a recognised criterion for weight-management treatment, and your prescriber may factor this into the overall plan.

If your codeine use is regular and long-term, your GP is the right person to review the combination alongside any new prescription. Our prescribers will ask about concurrent medicines directly during the consultation; they are not going to approve treatment without that information. The frequently asked questions page covers how the clinical review works in more detail. One practical note: once approved, your Mounjaro arrives via DPD the next working day in plain, unbranded packaging, but only after a real clinician has signed off the prescription, not before.

People sometimes search for shortcuts when it comes to obtaining tirzepatide. It is worth being direct: queries about a Mounjaro discount code or similar offers are common, and the honest answer is that no legitimate clinical service offers prescription medicines through promotional codes, a point our page on Mounjaro codes addresses directly for anyone who has come across them. The cost context for Mounjaro in the UK explains why price alone is the wrong measure for a prescription medicine.

When to get medical help

If you are already taking both codeine and tirzepatide and develop severe stomach pain that radiates to the back, with or without vomiting, seek urgent medical attention. The MHRA issued a Drug Safety Update in January 2026 highlighting acute pancreatitis as a known but infrequent risk with GLP-1 medicines; this needs to be ruled out promptly. Severe constipation that does not resolve with usual measures is also worth flagging to your prescriber or GP. If you follow a plant-based diet and have questions about the formulation, our page on whether Mounjaro is vegan covers the ingredients in detail. You can report any suspected side effects through the MHRA Yellow Card scheme. Our aftercare team is available seven days a week if a question comes up after treatment starts, reach us via the contact page.